Tenon Medical Stock Forecast

TNON's stock price has decreased by -59.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, Tenon Medical stock has a consensus rating of "Buy" and an average price target of $2.63. The average 1-year stock price forecast is 651.43% higher than the current stock price, while the lowest is $2.25 (+542.86%) and the highest is $3.00 (+757.14%).

Price Target: $2.63 (+651.43%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.25	$2.63	$2.63	$3.00
Change	+542.86%	+651.43%	+651.43%	+757.14%

* Price targets were last updated on May 14, 2026.

Analyst Ratings

The average analyst rating for Tenon Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Aug '25	Oct '25	Nov '25	Mar '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Buy Reiterates $3	Buy	Reiterates	$3	+757.14%	May 14, 2026
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Maintains $2.5 → $2.25	Buy	Maintains	$2.5 → $2.25	+542.86%	May 13, 2026

Financial Forecast

Revenue This Year

6.59M

from 3.94M

67.08%

from 3.94M

Revenue Next Year

9.71M

from 6.59M

47.38%

from 6.59M

EPS This Year

-0.85

from -1.70

EPS Next Year

-0.61

from -0.85

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	160.00K	691.00K	2.93M	3.28M	3.94M	6.59M
Revenue Growth	265.13%	331.88%	323.73%	11.92%	20.35%	67.08%
Gross Profit	105.00K	-641.00K	1.24M	1.71M	2.36M	4.52M
Gross Margin	65.63%	-92.76%	42.38%	52.21%	59.79%	68.55%
Operating Income	-6.46M	-18.15M	-15.73M	-13.77M	-12.01M	-13.06M
Net Income	-7.05M	-18.92M	-15.58M	-13.67M	-12.56M	-13.11M
EPS	-	-	-	-	-1.70	-0.85
Free Cash Flow	-2.79M	-7.36M	-6.91M	-4.65M	-6.16M	-7.09M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	7.0M
Avg	6.6M
Low	6.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	77.5%
Avg	67.1%
Low	56.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.85
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-